This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4qkj
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Glycosylated form of human LLT1, a ligand for NKR-P1, in this structure forming hexamers== |
| - | + | <StructureSection load='4qkj' size='340' side='right' caption='[[4qkj]], [[Resolution|resolution]] 2.75Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4qkj]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKJ FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |
| - | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qkg|4qkg]], [[4qkh|4qkh]], [[4qki|4qki]]</td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkj OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkj RCSB], [http://www.ebi.ac.uk/pdbsum/4qkj PDBsum]</span></td></tr> | |
| - | [[Category: | + | </table> |
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Blaha, J]] | ||
[[Category: Dohnalek, J]] | [[Category: Dohnalek, J]] | ||
[[Category: Duskova, J]] | [[Category: Duskova, J]] | ||
| - | [[Category: Stransky, J]] | ||
| - | [[Category: Blaha, J]] | ||
| - | [[Category: Vanek, O]] | ||
[[Category: Hasek, J]] | [[Category: Hasek, J]] | ||
[[Category: Koval, T]] | [[Category: Koval, T]] | ||
[[Category: Skalova, T]] | [[Category: Skalova, T]] | ||
| + | [[Category: Stransky, J]] | ||
| + | [[Category: Vanek, O]] | ||
| + | [[Category: Anchored in membrane on cell surface]] | ||
| + | [[Category: C-type lectin like fold]] | ||
| + | [[Category: Glcnac2man5 glycosylation]] | ||
| + | [[Category: Immune system]] | ||
| + | [[Category: Ligand for human receptor nkr-p1]] | ||
Revision as of 11:55, 11 March 2015
Glycosylated form of human LLT1, a ligand for NKR-P1, in this structure forming hexamers
| |||||||||||
